Literature DB >> 18480749

Characterization of CXCL16 and ADAM10 in the normal and transplanted kidney.

Anja Schramme1, Mohamed Sadek Abdel-Bakky, Paul Gutwein, Nicholas Obermüller, Patrick C Baer, Ingeborg A Hauser, Andreas Ludwig, Stefan Gauer, Liliana Schäfer, Ewelina Sobkowiak, Peter Altevogt, Michael Koziolek, Eva Kiss, Hermann-Josef Gröne, Ritva Tikkanen, Itamar Goren, Heinfried Radeke, Josef Pfeilschifter.   

Abstract

The chemokine CXCL16 plays an important role in the recruitment of leukocytes to sites of inflammation influencing the course of experimental glomerulonephritis. Here we show that human kidneys highly express CXCL16 in the distal tubule, connecting tubule and principal cells of the collecting duct with weak expression in the thick ascending limb of Henle. Beside the membrane localization, a soluble form of CXCL16 can be proteolytically released which acts as a chemotactic factor. In human renal tissue the expression pattern of the disintegrin-like metalloproteinase ADAM10 is similar to that of CXCL16, suggesting ADAM10 can potentially cleave CXCL16 in vivo. When we tested this in primary tubular cells we found that blockade of ADAM10 activity inhibited the IFN-gamma induced release of soluble CXCL16. Acute tubular damage in renal allografts was associated with elevated urinary CXCL16 and this correlated with focally increased apical CXCL16 expression in the distal tubules and collecting ducts. Renal allograft biopsies, with a histopathological diagnosis of acute interstitial rejection, showed increased basolateral ADAM10 expression together with high numbers of infiltrating T cells. Our results suggest that CXCL16 and ADAM10 are involved in the recruitment of T cells to the kidney and play an important role in inflammatory kidney diseases.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480749     DOI: 10.1038/ki.2008.181

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  20 in total

1.  An alternatively spliced CXCL16 isoform expressed by dendritic cells is a secreted chemoattractant for CXCR6+ cells.

Authors:  Robbert van der Voort; Viviènne Verweij; Theo M de Witte; Edwin Lasonder; Gosse J Adema; Harry Dolstra
Journal:  J Leukoc Biol       Date:  2010-02-24       Impact factor: 4.962

2.  Silencing of CXCL12 performs a protective effect on C5b-9-induced injury in podocytes.

Authors:  Wengang Sha; Lei Shen; Ling Zhou; Deyu Xu; Jing Yang; Guoyuan Lu
Journal:  Int Urol Nephrol       Date:  2018-03-05       Impact factor: 2.370

Review 3.  Secreted klotho and chronic kidney disease.

Authors:  Ming Chang Hu; Makoto Kuro-o; Orson W Moe
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

4.  Overexpression of CXCL16 in lesional psoriatic skin.

Authors:  Shin-Taek Oh; Anja Schramme; Wolfgang Tilgen; Paul Gutwein; Jörg Reichrath
Journal:  Dermatoendocrinol       Date:  2009-03

5.  CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein.

Authors:  Paul Gutwein; Mohamed Sadek Abdel-Bakky; Anja Schramme; Kai Doberstein; Nicole Kämpfer-Kolb; Kerstin Amann; Ingeborg A Hauser; Nicholas Obermüller; Christine Bartel; Abdel-Aziz H Abdel-Aziz; El Sayed M El Sayed; Josef Pfeilschifter
Journal:  Am J Pathol       Date:  2009-05-12       Impact factor: 4.307

6.  Activation of the CXCL16/CXCR6 pathway promotes lipid deposition in fatty livers of apolipoprotein E knockout mice and HepG2 cells.

Authors:  Kun Ling Ma; Yu Wu; Yang Zhang; Gui Hua Wang; Ze Bo Hu; Xiong Zhong Ruan
Journal:  Am J Transl Res       Date:  2018-06-15       Impact factor: 4.060

7.  ADAM10 is the major sheddase responsible for the release of membrane-associated meprin A.

Authors:  Christian Herzog; Randy S Haun; Andreas Ludwig; Sudhir V Shah; Gur P Kaushal
Journal:  J Biol Chem       Date:  2014-03-24       Impact factor: 5.157

8.  Immature renal dendritic cells recruit regulatory CXCR6(+) invariant natural killer T cells to attenuate crescentic GN.

Authors:  Jan-Hendrik Riedel; Hans-Joachim Paust; Jan-Eric Turner; André P Tittel; Christian Krebs; Erik Disteldorf; Claudia Wegscheid; Gisa Tiegs; Joachim Velden; Hans-Willi Mittrücker; Natalio Garbi; Rolf A K Stahl; Oliver M Steinmetz; Christian Kurts; Ulf Panzer
Journal:  J Am Soc Nephrol       Date:  2012-11-08       Impact factor: 10.121

9.  ADAM10 is expressed in human podocytes and found in urinary vesicles of patients with glomerular kidney diseases.

Authors:  Paul Gutwein; Anja Schramme; Mohamed Sadek Abdel-Bakky; Kai Doberstein; Ingeborg A Hauser; Andreas Ludwig; Peter Altevogt; Stefan Gauer; Anja Hillmann; Thomas Weide; Christine Jespersen; Wolfgang Eberhardt; Josef Pfeilschifter
Journal:  J Biomed Sci       Date:  2010-01-13       Impact factor: 8.410

10.  Canonical transforming growth factor-β signaling regulates disintegrin metalloprotease expression in experimental renal fibrosis via miR-29.

Authors:  Vasudev Ramdas; Martin McBride; Laura Denby; Andrew H Baker
Journal:  Am J Pathol       Date:  2013-10-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.